Ladenburg Thalmann Financial Services’s scPharmaceuticals SCPH Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Hold	357	–	–	﹤0.01%	5098
2019 Q3	$2K	Hold	357	–	–	﹤0.01%	4989
2019 Q2	$1K	Hold	357	–	–	﹤0.01%	5145
2019 Q1	$1K	Hold	357	–	–	﹤0.01%	5102
2018 Q4	$1K	Hold	357	–	–	﹤0.01%	5077
2018 Q3	$2K	Hold	357	–	–	﹤0.01%	4904
2018 Q2	$4K	Hold	357	–	–	﹤0.01%	4678
2018 Q1	$4K	Hold	357	–	–	﹤0.01%	4678
2017 Q4	$4K	Buy	+357	New	+$5.04K	﹤0.01%	4609

Other funds holding SCPH

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

AIM

Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SCPH Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its scPharmaceuticals (SCPH) position steady in Q4 2019 at 357 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5098.

Ladenburg Thalmann Financial Services first reported a position in SCPH in Q4 2017 and has held it in 9 quarters since. The position peaked at $4K in Q2 2018. 27 funds tracked by Wall St. Rank hold SCPH as of Q4 2019.

Ladenburg Thalmann Financial Services held 357 shares of scPharmaceuticals worth $2K as of Q4 2019.
Ladenburg Thalmann Financial Services left its scPharmaceuticals share count unchanged in Q4 2019.
scPharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5098 holding.
Ladenburg Thalmann Financial Services first reported a position in scPharmaceuticals in Q4 2017 and has held it in 9 quarters since.
Ladenburg Thalmann Financial Services's scPharmaceuticals position peaked at $4K in Q2 2018.
27 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.